S129: TAKEAIM LEUKEMIA- A PHASE 1/2A STUDY OF THE IRAK4 INHIBITOR EMAVUSERTIB (CA-4948) AS MONOTHERAPY OR IN COMBINATION WITH AZACITIDINE OR VENETOCLAX IN RELAPSED/REFRACTORY AML OR MDS

• G. Garcia-Manero,
• E. S. Winer,
• D. J. DeAngelo,
• S. Tarantolo,
• D. A. Sallman,
• J. Dugan,
• S. Groepper,
• A. Giagounidis,
• K. Götze,
• K. H. Metzeler,
• C.-C. Li,
• L. Zhou,
• E. Martinez,
• M. Lane,
• R. von Roemeling,
• M. Bohme,
• A. S. Kubasch,
• A. Verma,
• U. Platzbecker

Affiliations

G. Garcia-Manero

1 Luekemia, MD Anderson Cancer Center, Houston

E. S. Winer

2 Dana-Faber Cancer Institute, Boston

D. J. DeAngelo

2 Dana-Faber Cancer Institute, Boston

S. Tarantolo

3 Nebraska Cancer Specialist, Omaha

D. A. Sallman

4 Moffitt Cancer Center, Tampa

J. Dugan

5 Novant Health Cancer Institute, Forsyth Medical Center, Winston-Salem, United States of America

S. Groepper

6 Marien Hospital/ Univ. of Dusseldorf Germany, Dusseldorf

A. Giagounidis

6 Marien Hospital/ Univ. of Dusseldorf Germany, Dusseldorf

K. Götze

7 Faculty of Medicine Technical University of Munic, Munich

K. H. Metzeler

8 Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany

C.-C. Li

9 Curis, Lexington, United States of America

L. Zhou

9 Curis, Lexington, United States of America

E. Martinez

9 Curis, Lexington, United States of America

M. Lane

9 Curis, Lexington, United States of America

R. von Roemeling

9 Curis, Lexington, United States of America

M. Bohme

9 Curis, Lexington, United States of America

A. S. Kubasch

10 University Hospital Leipzig, Leipzig, Germany

A. Verma

11 Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, United States of America

U. Platzbecker

10 University Hospital Leipzig, Leipzig, Germany